Global Postmenopausal Vaginal Atrophy Pva Drugs Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2022 –2029 |
 Market Size (Base Year) |
USD 2.00 Billion |
 Market Size (Forecast Year) |
USD 3.57 Billion |
 CAGR |
% |
| Major Markets Players |
全球绝经后阴道萎缩 (PVA) 药物市场，按药物（外用雌激素、口服雌激素等）、产品（乳膏、阴道栓剂、药片、凝胶、溶液、插入物等）、最终用户（医院、家庭护理、专科诊所等）、分销渠道（医院药房、网上药房、零售药房）划分 - 行业趋势和预测至 2029 年。
绝经后阴道萎缩 (PVA) 药物市场分析及规模
预计全球绝经后阴道萎缩 (PVA) 药物市场将在预测期内出现显著增长。这种疾病的常见症状包括刺激、灼热感、发红和性交困难。市场上有几种品牌和仿制药可用于治疗绝经后阴道萎缩。顶级非雌激素药物的开发也帮助市场在近年来取得了进展。除此之外，加强医疗改革以满足治疗阴道萎缩的要求也是推动市场发展的主要因素。
Data Bridge Market Research 分析了 2022-2029 年预测期内全球绝经后阴道萎缩 (PVA) 药物市场的增长率。在上述预测期内，全球绝经后阴道萎缩 (PVA) 药物市场的预期复合年增长率趋于 7.50% 左右。2021 年市场价值为 20 亿美元，到 2029 年将增长至 35.7 亿美元。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、渠道分析、定价分析和监管框架。
绝经后阴道萎缩 (PVA) 药物市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2020（可定制为 2014 - 2019） |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
药物（外用雌激素、口服雌激素、其他）、产品（乳膏、阴道栓剂、药片、凝胶、溶液、插入物、其他）、最终用户（医院、家庭护理、专科诊所、其他）、分销渠道（医院药房、网上药房、零售药房） |
|
覆盖国家 |
北美洲的美国、加拿大和墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲其他地区 |
|
涵盖的市场参与者 |
Pfizer Inc (U.S.), Mylan N.V. (U.S.), Novartis AG (Switzerland), Hikma Pharmaceuticals plc (U.K.), Aurobindo Pharma (India), AbbVie Inc. (Ireland), Melinta Therapeutics, Inc (U.S.), Bristol-Myers Squibb Company (U.S.), GSK plc. (U.K.), Bayer AG (Germany), Lupin (India), Perrigo Company plc (U.S.), Bionovo, Inc. (Saudi Arabia), TherapeuticsMD, Inc. (U.S.), Endoceutics, Inc (Canada) |
|
Market Opportunities |
|
Market Definition
Postmenopausal vaginal atrophy (PVA) is the type of condition of vaginal wall thinning the reduced level of estrogen causes that. The changes in the genitourinary tract arising from a hypoestrogenic state includes decreased vaginal vascularization, reduced vaginal lubrication, thinning of the vaginal epithelium. The pH level continuously increases and loss of lactobacilli microflora allows opportunistic colonization by pathogenic bacteria can produce infection.
Global Postmenopausal Vaginal Atrophy (PVA) Drugs Market Dynamics
Drivers
- Prevalence of Postmenopausal Vaginal Atrophy
The increasing incidence of postmenopausal vaginal atrophy boosts the demand for treatment methods. The most prevalent symptom is vaginal dryness which affects 60% of women in the postmenopausal period. These symptoms can generally lead to sexual dysfunction and subsequently to reduced quality of life.
- Growing Healthcare Plans
Numerous established healthcare infrastructures, as well as the increased frequency of disease and the occurrence of significant manufacturers, are the primary factors contributing to the market share. For instance, The Affordable Care Act has increased the number of insured women and has been a boosting factor in the treatment-seeking behavior of people with this condition. Furthermore, this law provides many U.S. citizens with better health security by putting in place comprehensive health insurance reforms that have reduced healthcare costs and expanded coverage. Consequently, the introduction of beneficial healthcare plans in the US will prompt more women to seek treatment, thereby helping in the growth of this market during the forecast period.
Opportunities
- Increased Awareness of the Disease
The rising awareness among the population about this kind of disease results in the market's growth. The growing awareness about the benefits of postmenopausal vaginal atrophy drugs encourages people to opt for this treatment. Furthermore, in developed countries such as the US, women can openly discuss their symptoms with their physician, which creates awareness and helps in early diagnosis, thus encouraging this market growth.
- Increasing Demand for Retail Pharmacies
The rise in the number of postmenopausal vaginal atrophy drugs delivered through retail pharmacies and the surge in the number of retail pharmacies in highly advanced countries create much opportunities for the market growth. Additionally, patients choose retail pharmacies for purchasing drugs, as these are easily available.
Restraints/Challenges
- Lack of Awareness about the infection
The lack of awareness about these infections could curb the growth of the global postmenopausal vaginal atrophy drugs market over a forecast period. Not much attention about the infection leads to improper treatment thus restraining the market growth.
- High Cost
The huge expenditure associated with these agents surely hamper the market growth. Several antifungal, antiviral, antibacterial drugs are facing an increasing hike and thus is hampering the market growth.
This global postmenopausal vaginal atrophy (PVA) drugs market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global postmenopausal vaginal atrophy (PVA) drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Global Postmenopausal Vaginal Atrophy (PVA) Drugs Market
The COVID-19 pandemic has hindered the development, production, and supply of drugs and other healthcare products and affected many companies' growth of healthcare businesses worldwide. However, in the post-pandmeic era, the market is projected to grow because of an increase in R&D initiatives for exact diagnosis. Numerous government and non-government bodies, including the European Institute of Women's Health (EIWH) and the World Health Organization, have launched multiple public awareness campaigns about women's health.Thus, COVID-19 left a major imapact on the global postmenopausal vaginal atrophy (PVA) drugs market.
Global Postmenopausal Vaginal Atrophy (PVA) Drugs Market Scope
The global postmenopausal vaginal atrophy (PVA) drugs market is segmented on the basis of drugs, product, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Drugs
- Topical Estrogen
- Oral Estrogen
- Others
Product
- Creams
- Pessaries
- Tablets
- Gels
- Solutions
- Inserts
- Others
End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Postmenopausal Vaginal Atrophy (PVA) Drugs Market Regional Analysis/Insights
The global postmenopausal vaginal atrophy (PVA) drugs market is analyzed and market size insights and trends are provided by drugs, product, distribution channel and end-user as referenced above.
全球绝经后阴道萎缩 (PVA) 药物市场报告涵盖的主要国家 包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。
由于政府和制药组织采取越来越多的举措来提高人们对女性阴道感染的认识并增加其发病率，在预测期内，亚太地区的全球绝经后阴道萎缩 (PVA) 药物市场一直呈现积极增长态势。
北美占据了市场主导地位，因为制药组织不断采取主动措施，开发新配方，并在最终用户中广泛传播抗感染药物的认知。
报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。此外，在提供国家数据预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈竞争或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
竞争格局和全球绝经后阴道萎缩 (PVA) 药物市场份额分析
全球绝经后阴道萎缩 (PVA) 药物市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司关注的全球绝经后阴道萎缩 (PVA) 药物市场相关。
全球绝经后阴道萎缩 (PVA) 药物市场的主要参与者包括：
- 辉瑞公司 (美国)
- Mylan NV（美国）
- 诺华公司（瑞士）
- Hikma Pharmaceuticals plc（英国）
- Aurobindo Pharma（印度）
- AbbVie Inc.（爱尔兰）
- Melinta Therapeutics, Inc（美国）
- 百时美施贵宝公司 (美国)
- 葛兰素史克公司（英国）
- 拜耳公司（德国）
- 鲁冰花（印度）
- Perrigo Company plc（美国）
- Bionovo, Inc.（沙特阿拉伯）
- TherapeuticsMD, Inc.（美国）
- Endoceutics, Inc（加拿大）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
